Cutaneous lymphoid hyperplasias.

Area of Science:

• Dermatology
• Pathology
• Immunology

Background:

• Benign skin lymphoid infiltrates, previously termed pseudolymphoma, present with clinical and histological features resembling lymphoma.
• These infiltrates are categorized as B-cell predominant (e.g., cutaneous lymphoid hyperplasia, Kimura's disease) or T-cell predominant (e.g., lymphomatoid drug eruption).
• They often arise from exaggerated immune responses to external triggers like insect bites, tattoos, or trauma.

Purpose of the Study:

• To differentiate benign lymphoid infiltrates from cutaneous lymphoma.
• To outline diagnostic approaches for these conditions.
• To discuss management strategies and long-term patient observation.

Main Methods:

• Comprehensive assessment integrating clinical presentation and behavior.
• Routine histology and histopathology.
• Immunophenotyping and molecular studies for clonal analysis.

Main Results:

• A significant proportion of cases exhibit occult B- or T-cell clones, termed clonal cutaneous lymphoid hyperplasia (CLH).
• While generally benign, a minority of patients with clonal CLH may progress to overt cutaneous lymphoma.
• Diagnosis necessitates a multidisciplinary approach.

Conclusions:

• Accurate diagnosis of benign cutaneous lymphoid infiltrates relies on a composite assessment of clinical, histological, immunophenotypic, and molecular data.
• Treatment varies based on the specific condition and its behavior, typically involving antibiotics, corticosteroids, or immunosuppressants.
• Close monitoring is crucial for patients with clonal populations and persistent lesions due to the risk of lymphoma transformation.